Fred Hassan

Insider Reports History

Location
Boca Raton, FL
Signature
/s/ Fred Hassan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred Hassan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PRECIGEN, INC. Director Common Stock 1.15M $2.01M $1.74 14 Mar 2025 Direct
Cocrystal Pharma, Inc. Director Common Stock 1.38M $1.92M $1.39 28 Oct 2025 Direct
Cocrystal Pharma, Inc. Director Warrants 719K $1M $1.39 28 Oct 2025 Direct
BridgeBio Pharma, Inc. Director Common Stock 25.9K $850K $32.84 20 Jun 2025 Direct
PRECIGEN, INC. Director Restricted Stock Units 0 $0 $1.74 14 Mar 2025 Direct
PRECIGEN, INC. Director Option to Purchase Common Stock (Right to Buy) 83.5K 13 Mar 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Options (Right to buy) 60K 03 Sep 2024 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 40K 03 Jan 2025 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 8.43K 20 Jun 2025 Direct
Prometheus Biosciences, Inc. Director Common Stock 0 $108.42 16 Jun 2023 Direct
Prometheus Biosciences, Inc. Director Stock Option (right to buy) 0 16 Jun 2023 Direct

Insider Reports Filed by Fred Hassan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COCP Cocrystal Pharma, Inc. 28 Oct 2025 2 $1.5M 4 Director 30 Oct 2025, 16:15
BBIO BridgeBio Pharma, Inc. 20 Jun 2025 2 $0 4 Director 24 Jun 2025, 18:56
PGEN PRECIGEN, INC. 13 Mar 2025 5 $63K 4 Director 17 Mar 2025, 18:33
EYPT EyePoint Pharmaceuticals, Inc. 03 Jan 2025 1 $0 4 Director 07 Jan 2025, 16:05
COCP Cocrystal Pharma, Inc. 09 Oct 2024 1 $0 4 Director 11 Oct 2024, 16:05
EYPT EyePoint Pharmaceuticals, Inc. 03 Sep 2024 0 $0 3 Director 05 Sep 2024, 16:02
EYPT EyePoint Pharmaceuticals, Inc. 03 Sep 2024 1 $0 4 Director 05 Sep 2024, 16:02
BBIO BridgeBio Pharma, Inc. 21 Jun 2024 1 $0 4 Director 25 Jun 2024, 17:39
PGEN PRECIGEN, INC. 14 Mar 2024 3 $63K 4 Director 18 Mar 2024, 18:20
PGEN PRECIGEN, INC. 09 Mar 2024 2 $0 4 Director 12 Mar 2024, 19:53
PGEN PRECIGEN, INC. 14 Aug 2023 1 $998K 4 Director 16 Aug 2023, 16:31
COCP Cocrystal Pharma, Inc. 18 Jul 2023 1 $0 4 Director 20 Jul 2023, 16:05
BBIO BridgeBio Pharma, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:19
RXDX Prometheus Biosciences, Inc. 16 Jun 2023 4 $0 4 Director 16 Jun 2023, 16:00
RXDX Prometheus Biosciences, Inc. 19 May 2023 1 $0 4 Director 19 May 2023, 17:39
COCP Cocrystal Pharma, Inc. 20 Apr 2023 0 $0 3 Director 27 Apr 2023, 16:01
PGEN PRECIGEN, INC. 09 Mar 2023 3 $56.5K 4 Director 13 Mar 2023, 17:02
PGEN PRECIGEN, INC. 22 Feb 2023 2 $0 4 Director 24 Feb 2023, 19:09
BBIO BridgeBio Pharma, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:29
RXDX Prometheus Biosciences, Inc. 19 May 2022 1 $0 4 Director 20 May 2022, 19:20
PGEN PRECIGEN, INC. 25 Mar 2022 2 $0 4 Director 29 Mar 2022, 17:04
PGEN PRECIGEN, INC. 22 Feb 2022 3 $56.5K 4 Director 24 Feb 2022, 16:48
BBIO BridgeBio Pharma, Inc. 29 Dec 2021 1 $273K 4 Director 03 Jan 2022, 18:50
RXDX Prometheus Biosciences, Inc. 14 Nov 2021 1 $0 4 Director 16 Nov 2021, 20:19
BBIO BridgeBio Pharma, Inc. 17 Aug 2021 1 $0 4 Director 26 Aug 2021, 17:14
BBIO BridgeBio Pharma, Inc. 17 Aug 2021 0 $0 3 Director 26 Aug 2021, 16:31
RXDX Prometheus Biosciences, Inc. 14 May 2021 1 $0 4 Director 17 May 2021, 19:24
RXDX Prometheus Biosciences, Inc. 14 May 2021 0 $0 3 Director 17 May 2021, 19:17